Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001013762-23-003903

Chief Operating Officer gave up 37,126 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Mahal Jeetinder Singh · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-12 Shares withheld for taxes : show line 1 in the form −37,126 $0.85 $31,557 250,097 D
Loading xslF345X05/ownership.xml…